<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01257191</url>
  </required_header>
  <id_info>
    <org_study_id>DAIT AADCRC-UCLA-02</org_study_id>
    <nct_id>NCT01257191</nct_id>
  </id_info>
  <brief_title>A Study to Compare the Effects of Different Sized Particles on Cells in the Nose</brief_title>
  <official_title>Cellular Inflammation Characterization of Nasal Challenges With Fine and Ultrafine Particles</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Los Angeles</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to see how the type and size of particles found in air pollution
      affects inflammation in the nose in people who are skin test positive to at least one
      allergen. It has been observed that pollution makes allergies worse. It has also been
      suggested that very small particles may affect allergies more than larger particles.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cough, bronchitis, asthma, and chronic obstructive pulmonary disease are all associated with
      elevated pollution particle levels. Researchers believe that particulate pollutants can
      exacerbate allergy and inflammation and affect asthma and allergy prevalence. In an urban
      setting such as the Los Angeles Basin, particles generated by vehicular traffic are thought
      to be important risk factors. Recently, the Environmental Health Centre of Southern
      California confirmed that there is a strong association between traffic near homes and
      schools and development of asthma. This study will help researchers describe the effects of
      various size pollution particles in causing inflammation in the nose.

      There will be a total of 20 study visits. The study procedures include physical exams,
      symptom score for nose, nose washes and nose challenges with particulate matter. The
      particulates will be given in a random order and include the following: saline (sterile salt
      water), inert carbon particles (Carbon Black), diesel exhaust particles (DEP), small (fine)
      particles or very small (ultrafine) particles. These last two (fine and ultrafine) particles
      are obtained from concentrated normal Los Angeles air. The particulate will be sprayed into
      the nose with a standard nasal spray.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The number of inflammatory cells in nasal lavage samples after exposure to 4 different types of particles</measure>
    <time_frame>6 and 24 hours after nasal challenge</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Differential cell count in nasal lavages</measure>
    <time_frame>6 and 24 hours post challenge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IL-8 in nasal lavages</measure>
    <time_frame>6 and 24 hours post challenge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TNFα in nasal lavages</measure>
    <time_frame>6 and 24 hours post challenge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>RANTES in nasal lavages</measure>
    <time_frame>6 and 24 hours post challenge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MCP-1 in nasal lavages</measure>
    <time_frame>6 and 24 hours post challenge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MIP-1α in nasal lavages</measure>
    <time_frame>6 and 24 hours post challenge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GM-CSF in nasal lavages</measure>
    <time_frame>6 and 24 hours post challenge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nitrite in nasal lavages</measure>
    <time_frame>6 and 24 hours post challenge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Induced ROS generation (presence of intracellular thiol, 8-Isoprostane, and hydrogen peroxide) in nasal lavage cells</measure>
    <time_frame>6 and 24 hours post challenge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phase II enzymes (HO-1, GSTP1, NQO1 and GSTM1) in nasal lavage</measure>
    <time_frame>6 and 24 hours post challenge</time_frame>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Hypersensitivity, Immediate</condition>
  <condition>Atopic Hypersensitivity</condition>
  <arm_group>
    <arm_group_label>Carbon Black</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Diesel Exhaust Particles</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Fine Concentrated Ambient Particles</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Ultrafine Concentrated Ambient Particles</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Carbon Black</intervention_name>
    <description>source: commercial</description>
    <arm_group_label>Carbon Black</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diesel Exhaust Particles</intervention_name>
    <description>source: diesel engine</description>
    <arm_group_label>Diesel Exhaust Particles</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fine Concentrated Ambient Particles</intervention_name>
    <description>source: concentrated ambient air</description>
    <arm_group_label>Fine Concentrated Ambient Particles</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ultrafine Concentrated Ambient Particles</intervention_name>
    <description>source: concentrated ambient air</description>
    <arm_group_label>Ultrafine Concentrated Ambient Particles</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>Saline solution</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Previously determined high inflammatory responders to Diesel Exhaust Particles

          -  Previously determined atopy as demonstrated by allergy skin testing

          -  Asymptomatic on day of challenge.

        Exclusion Criteria:

          -  History of lung problems (including asthma), bleeding, neuromuscular, liver, kidney or
             heart disorders.

          -  History of anaphylaxis.

          -  Recent upper respiratory infection (less than 4 weeks prior to study) or other active
             infection.

          -  Active smoker or smoker in the past 2 years.

          -  Treatment with topical nasal steroids (&lt; 1 month), systemic steroids (&lt;1 month), oral
             antihistamines (&lt; 1 week) prior to any nasal challenge.

          -  Use of leukotriene receptor antagonist (&lt; 1 month ) prior to any nasal challenge

          -  Intranasal antihistamine or cromolyn use &lt; 1 week prior to any nasal challenge .

          -  History of treatment with allergy immunotherapy.

          -  Inability to perform nasal lavage.

          -  Inability to give written informed consent

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria G Lloret, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California, Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.niaid.nih.gov</url>
    <description>National Institute of Allergy and Infectious Diseases (NIAID)</description>
  </link>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 7, 2010</study_first_submitted>
  <study_first_submitted_qc>December 7, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2010</study_first_posted>
  <last_update_submitted>January 9, 2017</last_update_submitted>
  <last_update_submitted_qc>January 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Los Angeles</investigator_affiliation>
    <investigator_full_name>Maria I. Garcia-Lloret, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Vehicle Emissions</keyword>
  <keyword>Diesel Exhaust</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Hypersensitivity, Immediate</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

